Concepedia

Author

Joseph Lawen

Dalhousie University

Also Known As

J G Lawen, J Lawen, J. LAWEN, J. Lawen, J.G Lawen, J.G. Lawen, JOSEPH G. LAWEN, JOSEPH LAWEN, JOSEPH Lawen, Joseph G Lawen

94

Publications

2.6K

Citations

23

H-Index

67

Concepts

All Affiliations

Dalhousie UniversityQueen Elizabeth II Health Sciences CentreVictoria General HospitalThe University of Texas at Austin
JL

About

Joseph Lawen is an author at Dalhousie University specializing in medicine, kidney transplant, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

25

1.1K

2

Health Sciences

2

2

47

3

Engineering

1

1

12

4

Behavioral Health

1

1

16

5

Biology

1

1

11

Joseph Lawen

×

46

Publications

2.4K

Citations

23

H-Index

YearCitations

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

Rainer Oberbauer, Giuseppe Segoloni, Josep M. Campistol,

Transplant International

2004

224

A RANDOMIZED, PROSPECTIVE MULTICENTER PHARMACOEPIDEMIOLOGIC STUDY OF CYCLOSPORINE MICROEMULSION IN STABLE RENAL GRAFT RECIPIENTS1,2,3

Paul Keown, David Landsberg, Ahmed Shoker,

Transplantation

1996

206

IS ROUTINE URETERIC STENTING NEEDED IN KIDNEY TRANSPLANTATION? A RANDOMIZED TRIAL

Javier Domínguez, Catherine M. Clase, Kamran Mahalati,

Transplantation

2000

190

Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation

Kamran Mahalati, P Belitsky, Kenneth A. West,

Journal of the American Society of Nephrology

2001

169

Growth Kinetics of Renal Masses: Analysis of a Prospective Cohort of Patients Undergoing Active Surveillance

Ross Mason, Mohamed Abdolell, Greg Trottier,

European Urology

2011

164

CAUSES OF GRAFT LOSS BEYOND TWO YEARS IN THE CYCLOSPORINE ERA

John M. Dunn, DEBBIE GOLDEN, Charles T. Van Buren,

Transplantation

1990

146

Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation

Bryce Kiberd, Joseph Lawen, Albert D. Fraser,

American Journal of Transplantation

2004

138

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12

Joseph Lawen, Elizabeth Davies, Georges Mourad,

Transplantation

2003

137

Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling

Catherine M. Clase, Kamran Mahalati, B. Kiberd,

American Journal of Transplantation

2002

107

The impact of vascular anastomosis time on early kidney transplant outcomes

Karim Marzouk, Joseph Lawen, Ian P.J. Alwayn,

Transplantation Research

2013

77

Page 1